Cargando…
Peptide-based materials for cancer immunotherapy
Peptide-based materials hold great promise as immunotherapeutic agents for the treatment of many malignant cancers. Extensive studies have focused on the development of peptide-based cancer vaccines and delivery systems by mimicking the functional domains of proteins with highly specific immuno-regu...
Autores principales: | Zhang, Lu, Huang, Yanyu, Lindstrom, Aaron Raymond, Lin, Tzu-Yin, Lam, Kit S, Li, Yuanpei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831480/ https://www.ncbi.nlm.nih.gov/pubmed/31695802 http://dx.doi.org/10.7150/thno.37194 |
Ejemplares similares
-
SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment
por: Zhang, Dalin, et al.
Publicado: (2022) -
HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy
por: Lin, Tzu-yin, et al.
Publicado: (2016) -
Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
por: Zhang, Tingting, et al.
Publicado: (2022) -
Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer
por: Lin, Tzu-yin, et al.
Publicado: (2012) -
Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo
por: Zhang, Lu, et al.
Publicado: (2020)